EUVIMEDEUVIMED entdecken
Crossref

Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B: In Vivo Study in a Fungal Keratitis Model

Muhammad Alif Sya'ban Mahfud, Nor Atikah Syahirah, Muhammad Akram, Ulfah Mahfufah, Mesakh Diki Saputra, Diany Elim, Maqhfirah Nurul Fitri Andi, Nurul Aisha Fitri Sultan, Achmad Himawan, Juan Domínguez-Robles, Boonnada Pamornpathomkul, Maria Mir und 1 weitere

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.3c00647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Muhammad Alif Sya'ban Mahfud und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Hasanuddin University, Makassar 90245, Indonesia. Hauptthemen laut MEDLINE: Keratitis, Eye Infections, Fungal, Corneal Ulcer. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Universitas Hasanuddin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal keratitis (FK) is a fungal infection of the cornea, which is part of the eye and causes corneal ulcers and an increased risk of permanent blindness, which is often found in Candida albicans species. Amphotericin B (AMB), which is a group of polyenes as the first-line treatment of FK, is effective in annihilating C. albicans. However, AMB preparations such as eye drops and ointments have major drawbacks, for instance, requiring more frequent administrations, loss of the drug by the drainage process, and rapid elimination in the precornea, which result in low bioavailability of the drug. An ocular dissolving microneedle containing the solid dispersion amphotericin B (DMN-SD-AMB) had been developed using a mixture of poly(vinyl alcohol) (PVA) and poly(vinylpyrrolidone) (PVP) polymers, while the solid dispersion AMB (SD-AMB) was contained in the needle as a drug. This study aims to determine the most optimal and safest DMN-SD-AMB formula for the treatment of FK in the eye as well as a solution to overcome the low bioavailability of AMB eye drops and ointment preparations. SD-AMB had been successfully developed, which was characterized by increased antifungal activity and drug release in vitro compared to other treatments. Furthermore, DMN-SD-AMB studies had also been successfully performed with the best formulation, which exhibited the best ex vivo corneal permeation profile and antifungal activity as well as being safe from eye irritation. In addition, an in vivo antifungal activity using a rabbit infection model shows that the number of fungal colonies was 0.98 ± 0.11 log10 CFU/mL (F3), 5.76 ± 0.32 log10 CFU/mL (AMB eye drops), 4.01 ± 0.28 log10 CFU/mL (AMB ointments), and 9.09 ± 0.65 log10 CFU/mL (control), which differed significantly (p < 0.05). All of these results evidence that DMN-SD-AMB is a new approach to developing intraocular preparations for the treatment of FK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratitisEye Infections, FungalCorneal UlcerAnimalsRabbitsAntifungal AgentsAmphotericin BCandidaOphthalmic SolutionsCandida albicans

Stichwörter der Autor:innen

Candida albicansamphotericin Bdissolving microneedlefungal keratitissolid dispersion

Substanzen

Antifungal AgentsAmphotericin BOphthalmic Solutions

Autor:innen und Institutionen

  • Faculty of Pharmacy, Hasanuddin University, Makassar 90245, Indonesia.
  • Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Seville 41012, Spain.
  • Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
  • Department of Pharmacy, Iqra University Islamabad Campus, Islamabad 45320, Pakistan.

ORCID-Profile: Andi Dian Permana

Förderung

  • Universitas Hasanuddin

Zitieren

APA

Mahfud, M. A. S., Syahirah, N. A., Akram, M., Mahfufah, U., Saputra, M. D., Elim, D., Andi, M. N. F., Sultan, N. A. F., Himawan, A., Domínguez-Robles, J., Pamornpathomkul, B., Mir, M., & Permana, A. D. (2023). Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B: In Vivo Study in a Fungal Keratitis Model. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00647

Vancouver

Mahfud MAS, Syahirah NA, Akram M, Mahfufah U, Saputra MD, Elim D, et al. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B: In Vivo Study in a Fungal Keratitis Model. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00647

BibTeX
@article{Mahfud2023,
  author = {Mahfud, Muhammad Alif Sya'ban and Syahirah, Nor Atikah and Akram, Muhammad and Mahfufah, Ulfah and Saputra, Mesakh Diki and Elim, Diany and Andi, Maqhfirah Nurul Fitri and Sultan, Nurul Aisha Fitri and Himawan, Achmad and Domínguez-Robles, Juan and Pamornpathomkul, Boonnada and Mir, Maria and Permana, Andi Dian},
  title = {Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B: In Vivo Study in a Fungal Keratitis Model},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.3c00647}
}
Kostenlos starten →